ALICIA SIEARS: Open Payments
NPI 1831508472 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,265 in 152 payments from 39 companies in 2025. Trend: 2023 $2,575 · 2024 $2,175 · 2025 $3,265
Food & beverage: $3,265
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $431 |
| AstraZeneca Pharmaceuticals LP | 14 | $262 |
| ABBVIE INC. | 8 | $215 |
| Daiichi Sankyo Inc. | 8 | $185 |
| PFIZER INC. | 10 | $173 |
| GENZYME CORPORATION | 7 | $156 |
| BeOne Medicines USA, Inc. | 8 | $140 |
| E.R. Squibb & Sons, L.L.C. | 7 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $134 |
| Hydrofera LLC | 1 | $125 |
Products named: Fabhalta, Enhertu, SARCLISA, EPKINLY, HYDROFERA BLUE, KISQALI, BRUKINSA, Nubeqa.
Industry payments across LA — which companies pay providers there.
